Cargando…

Are the polyol pathway and hyperuricemia partners in the development of non‐alcoholic fatty liver disease in diabetes?

Detalles Bibliográficos
Autores principales:	Hotta, Nigishi, Kawamura, Takahiko, Umemura, Toshitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378431/ https://www.ncbi.nlm.nih.gov/pubmed/31765518 http://dx.doi.org/10.1111/jdi.13190

Ejemplares similares

Does the breakdown of the detoxification system for aldehydes as a result of aldose reductase upregulation lead to alcohol‐induced liver injury in humans and mice?
por: Hotta, Nigishi, et al.
Publicado: (2020)

Curious relationship between cognitive impairment and diabetic retinopathy
por: Kawamura, Takahiko, et al.
Publicado: (2015)

Is there a place for inhibition of transforming growth factor‐β and the polyol pathway in therapy for diabetic retinopathy?
por: Hotta, Nigishi
Publicado: (2010)

Cognitive impairment in diabetic patients: Can diabetic control prevent cognitive decline?
por: Kawamura, Takahiko, et al.
Publicado: (2012)

Pathogenesis and neuroimaging of cerebral large and small vessel disease in type 2 diabetes: A possible link between cerebral and retinal microvascular abnormalities
por: Umemura, Toshitaka, et al.
Publicado: (2016)

Is cognitive impairment the fourth diabetic microvascular complication?
por: Kawamura, Takahiko, et al.
Publicado: (2011)

Retinopathy: A sign of cerebral small vessel disease in diabetes?
por: Umemura, Toshitaka, et al.
Publicado: (2017)

Neuroprotective properties of DPP‐4i: A therapeutic target for dementia prevention in elderly diabetic patients?
por: Umemura, Toshitaka, et al.
Publicado: (2023)

Effect of diabetes on stroke symptoms and mortality: Lessons from a recent large population‐based cohort study
por: Umemura, Toshitaka, et al.
Publicado: (2014)

Association of Chronic Kidney Disease and Cerebral Small Vessel Disease with Cognitive Impairment in Elderly Patients with Type 2 Diabetes
por: Umemura, Toshitaka, et al.
Publicado: (2013)

Obesity interacts with hyperuricemia on the severity of non-alcoholic fatty liver disease
por: Zhou, Mimi, et al.
Publicado: (2021)

Effect of renal impairment on cognitive function during a 3‐year follow up in elderly patients with type 2 diabetes: Association with microinflammation
por: Kawamura, Takahiko, et al.
Publicado: (2014)

Factors Associated with Changes in Brain Atrophy during a Three-Year Observation in Elderly Diabetic Patients: Effect of Renal Impairment on Hippocampal Atrophy
por: Kawamura, Takahiko, et al.
Publicado: (2016)

Challenges in the hepatic histopathology in non-alcoholic fatty liver disease
por: Brunt, Elizabeth M, et al.
Publicado: (2017)

Prevalence and Risk Factors of Hyperuricemia in Patients with Chronic Kidney Disease and Non-Alcoholic Fatty Liver
por: Golmohammadi, Sima, et al.
Publicado: (2020)

Pediatric non alcoholic fatty liver disease: more on novel treatment targets
por: Vajro, Pietro, et al.
Publicado: (2013)

Cancer surveillance in non-alcoholic fatty liver disease: A potential role for lipidomics
por: Best, Jan, et al.
Publicado: (2021)

A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis
por: Hotta, Nigishi
Publicado: (2019)

A new noninvasive technique for estimating hepatic triglyceride: will liver biopsy become redundant in diagnosing non-alcoholic fatty liver disease?
por: Betzel, Bark, et al.
Publicado: (2014)

Putting non-alcoholic fatty liver disease on the radar for primary care physicians: how well are we doing?
por: Sanyal, Arun J.
Publicado: (2018)

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation
por: Umemura, Toshitaka, et al.
Publicado: (2020)

Non-alcoholic fatty liver disease and diabetes
por: Hazlehurst, Jonathan M., et al.
Publicado: (2016)

Factors Associated with Cognitive Decline in Elderly Diabetics
por: Umegaki, Hiroyuki, et al.
Publicado: (2011)

CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease
por: Wang, Yinhan, et al.
Publicado: (2023)

Molecular pathways in non-alcoholic fatty liver disease
por: Berlanga, Alba, et al.
Publicado: (2014)

Redox imbalance stress in diabetes mellitus: Role of the polyol pathway
por: Yan, Liang‐jun
Publicado: (2018)

Polyol Pathway Exacerbated Ischemia/Reperfusion-Induced Injury in Steatotic Liver
por: Zhang, Changhe, et al.
Publicado: (2014)

We have become an Open Access journal!
por: Hotta, Nigishi
Publicado: (2014)

Why do we need a new journal now?
por: Hotta, Nigishi
Publicado: (2010)

Brave new world: Our journal has become an Open Access journal
por: Hotta, Nigishi
Publicado: (2015)

Like a snail, our journal (JDI) makes slow, but steady, progress
por: Hotta, Nigishi
Publicado: (2016)

A new era for research publication: Will Open Access become the norm?
por: Hotta, Nigishi
Publicado: (2019)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects
por: Toplak, Hermann, et al.
Publicado: (2016)

Fatty liver mediates the association of hyperuricemia with prediabetes and diabetes: a weighting-based mediation analysis
por: Basnet, Til Bahadur, et al.
Publicado: (2023)

Practice guidance documents for the diagnosis and management of non-alcoholic fatty liver disease—recent updates and open questions
por: Lauschke, Volker M.
Publicado: (2023)

Bariatric Surgery and Non-Alcoholic Fatty Liver Disease: Current and Potential Future Treatments
por: Sasaki, Akira, et al.
Publicado: (2014)

The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease
por: Werge, Mikkel Parsberg, et al.
Publicado: (2021)

The Polyol Pathway as a Mechanism for Diabetic Retinopathy: Attractive, Elusive, and Resilient
por: Lorenzi, Mara
Publicado: (2007)

Non-alcoholic fatty liver disease and diabetic retinopathy: Is there an association?
por: Jacob, Mathew, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v1veo7156p02bd114la62jjaof